3rd European Workshop on
Skin Immune Mediated Inflammatory Diseases (SIMID)
24 September 2020 - 24 March 2021

Faculty

  • Georg Stingl

    Department of Dermatology Medical University of Vienna, Austria

    Langerhans cells and dendritic cells in skin immunity

  • Wolf Henning Boehncke

    Dermatology Unit University of Geneve, Switzerland

    Autoreactive T-lymphocytes in skin diseases

  • Claudia Traidl-Hoffmann

    Department of Environmental Medicine, UniKlinikum Augsburg, Germany

    Skin – microbe interaction as a function of skin homeostasis

  • Angelo Valerio Marzano

    Dermatology Unit, Fondazione IRCCS Ca’ Granda
    Ospedale Maggiore Policlinico, Milan, Italy
    Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Italy

    Neutrophilic dermatoses

  • Dagmar Simon

    Department of Dermatology, Inselspital, Bern
    University Hospital, University of Bern, Switzerland

    Eosinophilic dermatoses

  • Franco Rongioletti

    Dermatology Unit University of Cagliari, Italy

    Panniculitis: black beast of dermatologists and dermatopathologists

  • Cord Sunderkoetter

    University Hospital Halle Martin Luther University Halle-Wittenberg Department of Dermatology and Venerology, Halle Germany

    Vasculitis syndromes

  • Marta Mosca

    Rheumatology Unit, Azienda Ospedaliero Universitaria Pisana, Department of Clinical and Experimental Medicine, University of Pisa, Italy

    Lupus erythematosus

  • Marco Carrozzo

    Oral Medicine, School of Dental Sciences University of Newcastle upon Tyne, UK

    Oral lichen planus

  • Mauro Picardo

    Cutaneous Physiopathology Laboratory and Metabolomic Center, San Gallicano
    Dermatological Institute, Rome, Italy

    Vitiligo

  • Alain Taieb

    INSERM U 1035, University of Bordeaux, France

    Alopecia areata

  • Stefano Piaserico

    Dermatology Unit, Azienda Ospedaliero Universitaria of Padua, Italy

    Efficacy and safety of tildrakizumab the treatment of patients with psoriasis

  • Giuseppe Argenziano

    Dermatology Unit, University of Campania, Naples, Italy

    Efficacy and safety of risankizumab the treatment of patients with psoriasis

  • Mariateresa Rossi

    Dermatology Unit, Spedali Civili of Brescia, Italy

    Place in therapy of apremilast in the treatment of patients with psoriasis

  • Jo Lambert

    Department of Dermatology, Ghent University Hospital, Belgium

    Psoriasis: patient education

  • Andrea Conti

    Dermatology Unit, Azienda Ospedaliero Universitaria of Modena, Italy

    Efficacy and safety of brodalumab the treatment of patients with psoriasis

  • Paolo Gisondi

    Section of Dermatology, Department of Medicine, University of Verona, Italy

    The complete treatment of plaque psoriasis
    Management strategies for patients with psoriasis during the COVID-19 pandemic

  • Federico Bardazzi

    Dermatology Unit, Sant'Orsola Malpighi Hospital, Bologna, Italy

    Treatment of nail psoriasis

  • Hervé Bachelez

    Department of Dermatology, Saint-Louis Hospital, Paris, France

    Pustular psoriasis

  • Giovanna Zambruno

    Pathology Unit, Bambino Gesù Children's Hospital, Rome, Italy

    Pemphigoids

  • Michael Hertl

    Department of Dermatology and Allergology, Philipps
    University Hospital of Marburg, Germany

    Pemphigus

  • John Ingram

    Dermatology Unit Cardiff University Cardiff, UK

    Hidradenitis suppurativa: an update on multidisciplinary management

  • Martin Metz

    Dermatology Department of Dermatology and Allergy Charité – University of Berlin, Germany

    Urticaria

  • Maja Mockenhaupt

    Department of Dermatology, University Medical Center of Freiburg, Germany

    Cutaneous drug reactions

  • Rino Cerio

    Department of Cutaneous Medicine & Surgery, The Royal London Hospital & QMUL Bart's Health NHS Trust Whitechapel, London, UK

    Non infective cutaneous granulomatous diseases

  • Sonja Staender

    Münster University Hospital Department of Dermatology Center for Chronic Pruritus (KCP), Münster, Germany

    Itch: from new mediators to new treatments

  • Andrea Matucci

    Immunoallergology, Careggi University Hospital, Florence, Italy

    Discovering the science in type-2 inflammation

  • Lluís Puig

    Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona
    Universitat Autònoma de Barcelona School of Medicine, Barcelona, Spain

    Atopic dermatitis: charting the new therapeutic frontier

  • Giampiero Girolomoni

    Section of Dermatology, Department of Medicine, University of Verona, Italy

    Dupilumab in the treatment of atopic dermatitis

  • Qianjin Lu

    Department of Dermatology, Central South University, Changsha, Hunan, China

    Management strategies for patients with autoimmune diseases during the COVID-19 pandemic: a perspective from China